SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-002819
Filing Date
2021-04-27
Accepted
2021-04-27 17:24:48
Documents
5
Period of Report
2021-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_042721.htm 8-K 57294
2 EXHIBIT 3.1 exh_31.htm EX-3.1 20157
3 EXHIBIT 10.1 exh_101.htm EX-10.1 108454
4 EXHIBIT 99.1 exh_991.htm EX-99.1 14930
5 GRAPHIC logo.jpg GRAPHIC 10123
  Complete submission text file 0001171843-21-002819.txt   211322
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 21860177
SIC: 2836 Biological Products, (No Diagnostic Substances)